Clinical Trials

300 enrolled

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT07217990 2026-02-17

NoCUT-BC

84 enrolled

Phase NA Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07413146 2026-02-17

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

100 enrolled

Colonic Neoplasms, Neoplasm, Residual

NCT07244978 2025-12-02

Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

49 enrolled

Esophageal Squamous Cell Carcinoma

NCT07259122 2025-12-02

ZBR in WM

43 enrolled

Lymphoid

Waldenstrom Macroglobulinemia

NCT07254858 2025-11-28

CISN-L

302 enrolled

Breast Neoplasms

NCT07142863 2025-08-27

Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients

Phase 2/3 Not yet recruiting

23 enrolled

Sarcoma

Osteosarcoma

NCT07134218 2025-08-21

Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer

180 enrolled

Rectal Neoplasms

NCT06665217 2025-08-14

G-Pola-ZLP in Diffuse Large B-Cell Lymphoma

80 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT07089199 2025-07-28

TitAN

34 enrolled

Thoracic

NSCLC

NCT06980545 2025-05-20

Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer

50 enrolled

Stage III and IV Ovarian Cancer

NCT06957938 2025-05-08

Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma

168 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT06916117 2025-04-08

Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC

30 enrolled

Locally Advanced Cervical Cancer

NCT06889402 2025-03-21

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

600 enrolled

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms, Recurrence

NCT06868693 2025-03-11

PEACE

240 enrolled

Phase 2/3 Not yet recruiting

Pancreatic Neoplasms

NCT06769919 2025-01-10

A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer

340 enrolled

Breast Neoplasms

NCT06613308 2024-09-25

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06435104 2024-07-09

Aromatherapy in the Treatment of Early Breast Cancer

30 enrolled

Anxiety Disorders, Breast Neoplasms

NCT06325423 2024-03-26

Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

50 enrolled

Muscle-Invasive Bladder Carcinoma

NCT06304922 2024-03-12

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

45 enrolled

Ovarian Neoplasms

NCT06097416 2023-10-25

Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer

100 enrolled

Rectal Neoplasms

NCT04515602 2020-08-27

Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)

410 enrolled